RAPAMUNE sol 1 mg/ml fl 60 ml

7680552430024 CH-55243 L04AH01 07.15.0.
RAPAMUNE sol 1 mg/ml fl 60 ml
RAPAMUNE sol 1 mg/ml fl 60 ml
RAPAMUNE sol 1 mg/ml fl 60 ml
1 / 3
google

Details

Product number
5524301
CPT
-
Packaging group
60
Unit
ml
Composition
sirolimusum 1 mg, polysorbatum 80, phosphatidylcholinum, sojae oleum 20 mg, mono/diglycerida, ethanolum 96 per centum 20 mg, propylenglycolum 350 mg, E 304, ad solutionem pro 1 ml, ethanolum 3.17 % V/V.

Articles (1)

Rapamune 1 mg/ml, Lösung zum Einnehmen
Lösung
60
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
07/11/2024
Professional SmPC
Français
07/11/2024
Professional SmPC
Italien
07/11/2024
Patient information leaflet
Allemand
19/10/2022
Patient information leaflet
Français
19/10/2022
Patient information leaflet
Italien
19/10/2022

Detailed composition

Substance Quantity Type Category
(N/A)
1.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
20.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
20.0 MG Substance HBESI
(N/A)
350.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
3.17 PVV Substance HNIDK

Reimbursement information

Public price
CHF 279.80
Specialties list
Yes
Generic
No
SL addition date: 01/04/2001

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
55243
Drug name
Rapamune, Lösung zum Einnehmen
Galenic form
LSOR
ATC Code
L04AH01
Authorization status
Z
Dispensation category
B
First authorization
26/09/2000
Authorization expiration date
31/12/9999
IT number
07.15.0.
Domain
Human medicine
Field of application
Immunsuppressivum

Packaging details

Description (FR)
RAPAMUNE sol 1 mg/ml fl 60 ml
Description (DE)
RAPAMUNE Lös 1 mg/ml Fl 60 ml
Market launch
26/09/2000
Narcotic (BTM)
No